Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 20

Results For "President"

2636 News Found

Lupin enters China market with approval for Oseltamivir oral suspension
Drug Approval | May 22, 2026

Lupin enters China market with approval for Oseltamivir oral suspension

The approval has been secured in partnership with Yabao Pharmaceuticals, a major player in China’s paediatric medicine segment


QIAGEN and NVIDIA partner on AI drug discovery
R&D | May 21, 2026

QIAGEN and NVIDIA partner on AI drug discovery

Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases


Drug Safety Symposium 2026 to focus on real-world impact of pharmacovigilance
News | May 21, 2026

Drug Safety Symposium 2026 to focus on real-world impact of pharmacovigilance

The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations


Pfizer advances next-gen pneumococcal vaccine after strong Phase 2 infant data
Clinical Trials | May 21, 2026

Pfizer advances next-gen pneumococcal vaccine after strong Phase 2 infant data

Pfizer says the broader dataset across all 25 serotypes strengthens confidence that the program can meet non-inferiority thresholds in its upcoming Phase 3 pediatric trials


Lilly's retatrutide delivers 30% weight loss in Phase 3 TRIUMPH-1 trial
News | May 21, 2026

Lilly's retatrutide delivers 30% weight loss in Phase 3 TRIUMPH-1 trial

All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks


Boston Scientific invests $1.5 billion in MiRus for TAVR expansion
Medical Device | May 20, 2026

Boston Scientific invests $1.5 billion in MiRus for TAVR expansion

Deal includes exclusive option to acquire MiRus’ SIEGEL TAVR system for an additional $3 billion upon milestone achievements


Apothecon Pharma appoints Shyamakant Giri as Group CEO
People | May 20, 2026

Apothecon Pharma appoints Shyamakant Giri as Group CEO

In his new role, he will lead the growth strategy for the group’s operations, including Apothecon Pharmaceuticals in India and Navinta LLC in the United States


Regeneron signs $2.32 billion deal with Parabilis for Helicon conjugates
News | May 20, 2026

Regeneron signs $2.32 billion deal with Parabilis for Helicon conjugates

The multi-target collaboration combines Regeneron’s industry-leading antibody capabilities with Parabilis’ novel Helicon peptide platform


Amita Patni appointed VP- Global Procurement Head at Shalina Healthcare
People | May 20, 2026

Amita Patni appointed VP- Global Procurement Head at Shalina Healthcare

She brings extensive expertise in managing global and domestic procurement operations